drugset / Trial / NCT05573724
Drug-drug Interaction Study With AZD5305 and Itraconazole in Patients With Advanced Solid Malignancies
NaSingle-groupOpen-labelTreatment
Summary
This study is a single-arm, open-label, multi-centre drug-drug interaction (DDI) study of AZD5305 administered orally in patients with advanced solid tumours.
Timeline
- Start
- 2022-11-07
- Primary completion
- 2023-04-17
- Completion
- 2024-05-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | — | Oral |
| Subject | Saruparib | Small molecule | — | Oral |